Vera Therapeutics, Inc. — Form 4/A
Filed August 12, 2026 · analyzed by the Insider Agent
4/A
▼ Likely negative
significance 39/100
What the filing says
PRESIDENT AND CEO Fordyce Marshall (VERA) sold 37K shares (~$680K) on the open market (5.9% of holdings). Open-market sale — often routine.
Why this rating
Open-market sale — often routine.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.